简化LI-RADS在钆塞酸增强MRI诊断肝细胞癌中的应用
本研究回顾性纳入510例患者645个≤30mm结节,评估简化LI-RADS(单一大小标准≥10mm,策略B)在钆塞酸增强MRI诊断HCC的效能。简化LI-RADS联合移行期低信号较LI-RADS v2018提高敏感度(82% vs 73%),特异度无显著降低(94% vs 96%),并缩短分类时间(44秒 vs 74秒)。
要点
- 简化LI-RADS采用单一大小标准(≥10mm),策略B(对10-19mm和≥20mm结节均用≥20mm分类)较策略A敏感度更高(74% vs 73%)。
- 简化LI-RADS联合策略B和移行期低信号较LI-RADS v2018提高敏感度(82% vs 73%),特异度无显著降低(94% vs 96%),并缩短分类时间。
诊断标准与关键数值
- 简化LI-RADS采用单一大小标准(≥10mm);策略A对10-19mm和≥20mm结节均使用10-19mm分类,策略B均使用≥20mm分类。
- 策略B诊断LR-5的敏感度74%(347/470,95%CI:70,78),特异度96%(168/175,95%CI:92,98)。
- 简化LI-RADS联合策略B和移行期低信号诊断LR-5的敏感度82%(387/470,95%CI:79,86),特异度94%(165/175,95%CI:90,97)。
- LI-RADS v2018诊断LR-5的敏感度73%(343/470,95%CI:69,77),特异度96%(168/175,95%CI:92,98)。
临床应用与阅片要点
- 对≤30mm结节,可考虑采用简化LI-RADS(单一大小标准≥10mm,策略B)以提高HCC诊断敏感度。
- 在LR-4(≥10mm,动脉期高强化,无其他主要特征)中,注意移行期低信号作为辅助特征,有助于HCC诊断。
- 简化LI-RADS可缩短分类时间,可能提高报告效率。
局限性
- 单中心回顾性研究,可能存在选择偏倚。
- 仅纳入接受切除、移植或活检的结节,存在验证偏倚。
- 简化LI-RADS策略需进一步外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Although various modifications to the Liver Imaging Reporting and Data System (LI-RADS) at gadoxetic acid-enhanced MRI have been suggested, LI-RADS shows suboptimal sensitivity for hepatocellular carcinoma (HCC) and is perceived to be too complex. Purpose To evaluate clinical usefulness of a simplified LI-RADS for diagnosing HCCs of 30 mm or smaller at gadoxetic acid-enhanced MRI. Materials and Methods Patients who underwent gadoxetic acid-enhanced MRI examination and subsequent resection, transplantation, or biopsy for focal solid nodules of 30 mm or smaller between January 2019 and December 2020 at a single tertiary referral institution were retrospectively analyzed. Two strategies for simplified LI-RADS using one size criterion (≥10 mm) were evaluated (strategy A, using classifications for nodules of 10-19 mm for nodules both 10-19 mm and ≥20 mm; strategy B, using classifications for nodules ≥20 mm for nodules both 10-19 mm and ≥20 mm). Multivariable analysis was performed to determine significant ancillary features for HCC. Generalized estimating equations were used to compare diagnostic performance for LR-5 (definite HCC) between LI-RADS version 2018 and simplified LI-RADS. The time required for LI-RADS category assignment was compared between the two systems with use of a paired t test. Results A total of 645 nodules from 510 patients (mean age ± SD, 60 years ± 10; 393 men) were evaluated. Compared with strategy A, strategy B had a higher sensitivity of 74% (347 of 470 nodules [95% CI: 70, 78]) vs 73% (342 of 470 nodules [95% CI: 69, 77]) (P = .02) with the same specificity of 96% (168 of 175 nodules [95% CI: 92, 98]) vs 96% (168 of 175 nodules [95% CI: 92, 98]) (P > .99). In strategy B, transitional phase hypointensity was an independent ancillary feature for HCC (P = .04) in LR-4 of at least 10 mm with arterial phase hyperenhancement and no other major features. In all 645 nodules, simplified LI-RADS with use of both strategy B and transitional phase hypointensity had a higher sensitivity of 82% (387 of 470 nodules [95% CI: 79, 86]) vs 73% (343 of 470 nodules [95% CI: 69, 77]) (P < .001) than LI-RADS version 2018, without lower specificity (94%, 165 of 175 nodules [95% CI: 90, 97] vs 96%, 168 of 175 nodules [95% CI: 92, 98], P = .08). Compared with LI-RADS version 2018, simplified LI-RADS reduced the time for LI-RADS category assignment (44 seconds ± 23 vs 74 seconds ± 22, P < .001). Conclusion A simplified Liver Imaging Reporting and Data System was found to be clinically useful for diagnosing hepatocellular carcinomas of 30 mm or smaller at gadoxetic acid-enhanced MRI. © RSNA, 2022 Online supplemental material is available for this article.
引用
- Kwag, Choi, Choi, et al. Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI. Radiology. 2022. PMID: 35972362. doi:10.1148/radiol.220659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。